Keywords: lipid, shows, mortality, benefit, pravastatin, bristol-myers, squibb
LIPID Shows Mortality Benefit With Pravastatin
Article | 18 November 1997
Bristol-Myers Squibb and Sankyo's lipid-lowering drug pravastatin hasbecome the latest member of the statin class to show a significant benefit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
